300
Participants
Start Date
June 30, 2012
Primary Completion Date
August 31, 2017
Study Completion Date
December 31, 2017
Lanreotide
Lanreotide will be administered once every 4 weeks as a subcutaneous injection
University Medical Center Groningen, Groningen
Leiden University Medical Center, Leiden
Radboud University Medical Center, Nijmegen
Erasmus Medisch Centrum, Rotterdam
Collaborators (1)
Leiden University Medical Center
OTHER
Erasmus Medical Center
OTHER
Radboud University Medical Center
OTHER
University Medical Center Groningen
OTHER